Exosome Diagnostics and Therapeutics Market by Product (Instrument, Reagent, and Software); By Application (Diagnostic, and Therapeutic); By End-User (Cancer Institute, Hospital, Diagnostic Center, and Others); By Geography (North America, Asia-Pacific, Europe, South America, and RoW), Industry Trends, Estimation & Forecast, 2018 – 2026

Check Today's Best Price

$3500 Buy Now
The Global Exosome Diagnostics and Therapeutics market is expected to reach $450 million by 2026, with a projected CAGR of 38.1% during the forecast period.
  • Market Overview

    The Global Exosome Diagnostics and Therapeutics market is expected to reach $450 million by 2026, with a projected CAGR of 38.1% during the forecast period. The global market is driven by rising prevalence of the chronic disease and its need for screening and diagnosing.

    Market Dynamics

    Growing incidence of cancer and chronic disorders, and rising demand for more development and research activities are the major factors driving the growth of the global exosome diagnostics and therapeutics market. However, stringent government regulations for the product approval, and low awareness about the applications of exosome in emerging economies are the major hindrances for the market growth. Moreover, advancements in technologies for easy exosome isolation and advanced exosome based products for new applications are some factors that is likely to gain significant impetus for the exosome diagnostics and therapeutics market share in the forthcoming years.

    Market Segmentation

    The study provides a crucial view of the exosome diagnostics and therapeutics by segmenting the market based on the product, application, end-user, and geography. The product segment includes instrument, reagent, and software. Diagnostic, and therapeutic, are the classification of the application segment. On the basis of end-user, the segment can be bifurcated into cancer institute, hospital, diagnostic center, and others. Furthermore, geographical coverage has been offered for each of the major regions including North America, Asia-Pacific, Europe, Row, and South America.

    Scope of the Global Exosome Diagnostics and Therapeutics Market

    By Product

    • Instrument
    • Reagent
    • Software

    By Application

    • Diagnostic
    • Therapeutic

    By End-User

    • Cancer Institute
    • Diagnostic Center
    • Hospital
    • Others

    By Geography

    • North America
      • The U.S.
      • Canada
      • Mexico
    • Europe
      • UK
      • France
      • Germany
      • Italy
      • Spain
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • Korea
      • Rest of APAC
    • South America
      • Brazil
      • Rest of South America
    • Rest of the World
      • Middle East
      • Africa
    keyboard_arrow_up
  • TABLE OF CONTENTS

    Chapter 1 Introduction
    1.1 Executive Summary
    1.2 Market Definition
    1.3 Market Scope

    Chapter 2 Research Methodology
    2.1 Primary Research
    2.2 Research Methodology
    2.3 Assumptions & Exclusions
    2.4 Secondary Data Products

    Chapter 3 Market Overview
    3.1 Report Segmentation & Scope
    3.2 Key Market Trends
    3.2.1 Drivers
    3.2.2 Restraints
    3.2.3 Opportunities
    3.3 Porter’s Five Forces Analysis
    3.4 Market Share Analysis

    Chapter 4 Global Exosome Diagnostics and Therapeutics Market by Product: Market Size and Forecast, 2018 – 2026
    4.1 Introduction
    4.1.1 Market Size and Forecast
    4.2 Instrument
    4.2.1 Market Size and Forecast
    4.3 Reagent
    4.3.1 Market Size and Forecast
    4.4 Software
    4.4.1 Market Size and Forecast

    Chapter 5 Global Exosome Diagnostics and Therapeutics Market by Application: Market Size and Forecast, 2018 – 2026
    5.1 Introduction
    5.1.1 Market Size and Forecast
    5.2 Diagnostic
    5.2.1 Market Size and Forecast
    5.3 Therapeutic
    5.3.1 Market Size and Forecast

    Chapter 6 Global Exosome Diagnostics and Therapeutics Market by End-User: Market Size and Forecast, 2018 – 2026
    6.1 Introduction
    6.1.1 Market Size and Forecast
    6.2 Cancer Institute
    6.2.1 Market Size and Forecast
    6.3 Diagnostic Center
    6.3.1 Market Size and Forecast
    6.4 Hospital
    6.4.1 Market Size and Forecast
    6.5 Others
    6.5.1 Market Size and Forecast

    Chapter 7 Global Exosome Diagnostics and Therapeutics Market by Geography: Market Size and Forecast, 2018 – 2026
    7.1 Introduction
    7.1.1 Market Size and Forecast
    7.2 North America
    7.2.1 North America Market Size & Forecast, By Country
    7.2.2 North America Market Size & Forecast, By Product
    7.2.3 North America Market Size & Forecast, By Application
    7.2.4 North America Market Size & Forecast, By End-User
    7.2.5 The U.S.
    7.2.5.1 Market Size and Forecast
    7.2.6 Canada
    7.2.6.1 Market Size and Forecast
    7.2.7 Mexico
    7.2.7.1 Market Size and Forecast
    7.3 Europe
    7.3.1 Europe Market Size and Forecast, By Country
    7.3.2 Europe Market Size and Forecast, By Product
    7.3.3 Europe Market Size and Forecast, By Application
    7.3.4 Europe Market Size & Forecast, By End-User
    7.3.5 UK
    7.3.5.1 Market Size and Forecast
    7.3.6 Germany
    7.3.6.1 Market Size and Forecast
    7.3.7 France
    7.3.7.1 Market Size and Forecast
    7.3.8 Italy
    7.3.8.1 Market Size and Forecast
    7.3.9 Spain
    7.3.9.1 Market Size and Forecast
    7.3.10 Rest of Europe
    7.3.10.1 Market Size and Forecast
    7.4 Asia-Pacific
    7.4.1 Asia-Pacific Market Size and Forecast, By Country
    7.4.2 Asia-Pacific Market Size and Forecast, By Product
    7.4.3 Asia-Pacific Market Size and Forecast, By Application
    7.4.4 Asia-Pacific Market Size and Forecast, By End-User
    7.4.5 India
    7.4.5.1 Market Size and Forecast
    7.4.6 China
    7.4.6.1 Market Size and Forecast
    7.4.7 Australia
    7.4.7.1 Market Size and Forecast
    7.4.8 Japan
    7.4.8.1 Market Size and Forecast
    7.4.9 South Korea
    7.4.9.1 Market Size and Forecast
    7.4.10 Rest of Asia-Pacific
    7.4.10.1 Market Size and Forecast
    7.5 South America
    7.5.1 South America Market Size and Forecast, By Country
    7.5.2 South America Market Size and Forecast, By Product
    7.5.3 South America Market Size and Forecast, By Application
    7.5.4 South America Market Size and Forecast, By End-User
    7.5.5 Brazil
    7.5.5.1 Market Size and Forecast
    7.5.6 Rest of South America
    7.5.6.1 Market Size and Forecast
    7.6 RoW
    7.6.1 RoW Market Size and Forecast, By Country
    7.6.2 RoW Market Size and Forecast, By Product
    7.6.3 RoW Market Size and Forecast, By Application
    7.6.4 RoW Market Size and Forecast, By End-User
    7.6.5 Middle East
    7.6.5.1 Market Size and Forecast
    7.6.6 Africa
    7.6.6.1 Market Size and Forecast

    Chapter 8 Company Profiles
    8.1 Aegle Therapeutics AMS Biotechnology (Europe) Limited
    8.2 Codiak BioSciences
    8.3 Evox Therapeutics Ltd.
    8.4 Exosome Diagnostics Inc.
    8.5 HansaBioMed Life Sciences Ltd. (Lonza)
    8.6 Miltenyi Biotec
    8.7 NonoSomiX Inc.
    8.8 System Biosciences (SBI)
    8.9 Thermo Fisher Scientific

    keyboard_arrow_up
  • Exosome Diagnostics and Therapeutics Market Key Players

    • Aegle Therapeutics AMS Biotechnology (Europe) Limited
    • Codiak BioSciences
    • Evox Therapeutics Ltd.
    • Exosome Diagnostics Inc.
    • HansaBioMed Life Sciences Ltd. (Lonza)
    • Miltenyi Biotec
    • NonoSomiX Inc.
    • System Biosciences (SBI)
    • Thermo Fisher Scientific
    keyboard_arrow_up


    • Keep your personal detail safe with us. Privacy Policy
      This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

CLIENTS

SHARE YOUR CART